Abstract:Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. Combined therapy has not improved the prognosis of osteosarcoma in the past five years, while new strategies need to be explored. We extracted serum exosomes from OS and healthy people. Contrasting to exosomes from healthy ones, those derived from patients suffering from OS significantly promoted the ability of adhesion, migration and viability of the MG63 in vitro study. Osteosarcoma-derived exosomes package proteins were mainly intracellular ones, while these proteins exclusively expressed glucose-6-phospate dehydrogenase (G6PD), phosphofructokinase, transaldolase 1 and transketolase that reprogrammed tumor metabolism and prompted progression of osteosarcoma. Western-blot assay confirmed osteosarcoma-derived exosomes contained generous G6PD than health people. In conclusion, serum exosomal proteins originated from osteosarcoma and healthy people were quite different from each other. Exosomes derived from osteosarcoma could promote tumor progression, for G6PD were largely packaged by serum exosomes. These special serum exosomes, which are abundant in G6PD, can be a promising target for diagnostic and therapeutic strategy for osteosarcoma.

Proteomic Identification Of Osteosarcoma-Derived Exosomes And Their Activation Of Pentose Phosphate Pathway